03034oam 2200781 450 991071522640332120220614140749.0(CKB)5470000002509763(OCoLC)1233296597(OCoLC)1237322777(OCoLC)995470000002509763(EXLCZ)99547000000250976320210129d2021 ua 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierCOVID-19: critical vaccine distribution, supply chain, program integrity, and other challenges require focused federal attention report to congressional committees[Washington, D.C.] :United States Government Accountability Office,2021.1 online resource (vii, 333 pages) color illustrations"January 2021.""GAO-21-265."Includes bibliographical references.COVID-19COVID-19 (Disease)VaccinationUnited StatesPlanningCOVID-19 (Disease)Economic aspectsUnited StatesCOVID-19 (Disease)DiagnosisUnited StatesCOVID-19 (Disease)United StatesPreventionCOVID-19 (Disease)TreatmentUnited StatesVaccines industryGovernment policyUnited StatesVaccinesDevelopmentUnited StatesPublic health administrationUnited StatesCOVID-19 (Disease)DiagnosisfastCOVID-19 (Disease)Economic aspectsfastCOVID-19 (Disease)PreventionfastCOVID-19 (Disease)TreatmentfastExpenditures, PublicfastPublic health administrationfastVaccines industryGovernment policyfastUnited StatesAppropriations and expendituresUnited StatesfastCOVID-19 (Disease)VaccinationPlanning.COVID-19 (Disease)Economic aspectsCOVID-19 (Disease)DiagnosisCOVID-19 (Disease)Prevention.COVID-19 (Disease)TreatmentVaccines industryGovernment policyVaccinesDevelopmentPublic health administrationCOVID-19 (Disease)Diagnosis.COVID-19 (Disease)Economic aspects.COVID-19 (Disease)Prevention.COVID-19 (Disease)Treatment.Expenditures, Public.Public health administration.Vaccines industryGovernment policy.GPOGPOOCLCOOCLCFOCLCOOCLCQS2HGPOBOOK9910715226403321COVID-19: critical vaccine distribution, supply chain, program integrity, and other challenges require focused federal attention3437581UNINA